HDHD5 Knockout AGS Polyclonal Cells represent a CRISPR/Cas9-mediated gene disruption model designed for the targeted loss of function of the HDHD5 gene in the AGS human gastric adenocarcinoma cell line. This polyclonal knockout cell population provides a versatile tool for studying HDHD5-dependent functions without the constraints of monoclonal selection, enabling diverse functional analyses in gastric cancer research.
The AGS host cell line was originally derived from a gastric adenocarcinoma of a 54-year-old female patient. These adherent epithelial cells retain characteristic features of the gastric mucosal epithelium and are extensively employed as a model system for investigating gastric adenocarcinoma biology, including tumor cell growth, invasion, and response to therapeutic agents. The AGS line provides a physiologically relevant background for dissecting the molecular mechanisms underlying gastric carcinogenesis and for evaluating the functional impact of gene-specific disruptions.
HDHD5 encodes a haloacid dehalogenase-like hydrolase belonging to the HAD superfamily, a diverse group of enzymes that catalyze phosphoryl transfer or hydrolysis reactions. Despite its classification, the precise enzymatic activity, physiological substrates, and molecular partners of HDHD5 remain uncharacterized. To date, no upstream regulators, downstream targets, or interacting factors have been identified for this protein. The mechanistic summary suggests a putative role in metabolic processes, but the detailed signaling network involving HDHD5 awaits elucidation. Its membership in the HAD superfamily hints at possible involvement in dephosphorylation or metabolite hydrolysis, yet functional studies are required to define these interactions.
In the AGS gastric cancer model, HDHD5 knockout offers a unique opportunity to explore the gene??s potential contributions to gastric adenocarcinoma progression. Since HDHD5 resides within the 22q11.2 chromosomal region, which is duplicated in cat eye syndrome, this model also provides a platform for investigating gene dosage effects linked to this congenital disorder. Phenotypic characterization of HDHD5-deficient AGS cells may reveal alterations in cell proliferation, migration, and apoptosis, thereby shedding light on both cancer-relevant and developmental pathways.
The HDHD5 Knockout AGS Polyclonal Cells are ideally suited for comprehensive functional genomics studies, including transcriptomic profiling via RNA-seq, validation of protein expression by Western blotting, and gene expression analysis by RT-qPCR. Functional assays such as cell proliferation, migration, and apoptosis assays can be performed to assess the biological consequences of HDHD5 loss. This polyclonal knockout model is particularly advantageous for large-scale screening and for capturing phenotypic variability arising from heterogeneous editing events. For additional product information, protocols, or technical assistance, please contact Ascent Research.
